Condition: Resolution of Inflammation · Reduction of Cell Proliferation · Sponsor: SCF Pharma
The purpose of this biological study is to provide Dr. Samuel Fortin's laboratory with a continuous supply of blood mononuclear cells (PBMCs) so that he can pursue research on the potential beneficial effects of monoglyceride omega-3 fatty acids on the resolution of inflammation.
This description comes directly from the study's public registry record.
Samuel Fortin, PhD · 418-750-8590 · sfortin@scfpharma.com
Anne-Julie Landry, M.Sc · ajlandry@scfpharma.com
Always discuss trial participation with your own doctor first.
| SCF Pharma | Rimouski, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05161702